Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 3071214, 10 pages
http://dx.doi.org/10.1155/2016/3071214
Research Article

Conditioning with Fludarabine-Busulfan versus Busulfan-Cyclophosphamide Is Associated with Lower aGVHD and Higher Survival but More Extensive and Long Standing Bone Marrow Damage

1Department of Hematology, Zhongshan Hospital of Sun Yat-Sen University and Zhongshan City People’s Hospital, Zhongshan 528403, China
2Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China

Received 29 April 2016; Revised 15 August 2016; Accepted 18 September 2016

Academic Editor: Francesco Onida

Copyright © 2016 Xin He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. D. Sung and N. J. Chao, “Concise review: acute graft-versus-host disease: immunobiology, prevention, and treatment,” Stem Cells Translational Medicine, vol. 2, no. 1, pp. 25–32, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. D. H. Sachs, T. Kawai, and M. Sykes, “Induction of tolerance through mixed chimerism,” Cold Spring Harbor Perspectives in Medicine, vol. 4, no. 1, Article ID a15529, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. S. G. Holtan, P. Marcelo, and D. J. Weisdorf, “Acute graft-versus-host disease: a bench-to-bedsideupdate,” Blood, vol. 124, no. 3, pp. 363–373, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. J. L. Ferrara, J. E. Levine, P. Reddy, and E. Holler, “Graft-versus-host disease,” The Lancet, vol. 373, no. 9674, pp. 1550–1561, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. J. Messmann, T. Reisser, F. Leithäuser, M. B. Lutz, K.-M. Debatin, and G. Strauss, “In vitro-generated MDSCs prevent murine GVHD by inducing type 2 T cells without disabling antitumor cytotoxicity,” Blood, vol. 126, no. 9, pp. 1138–1148, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Hülsdünker and R. Zeiser, “Insights into the pathogenesis of GvHD: what mice can teach us about man,” Tissue Antigens, vol. 85, no. 1, pp. 2–9, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. T. V. Brennan, V. R. Rendell, and Y. Yang, “Innate immune activation by tissue injury and cell death in the setting of hematopoietic stem cell transplantation,” Frontiers in Immunology, vol. 6, Article ID 00101, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Chakraverty, D. Côté, J. Buchli et al., “An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues,” Journal of Experimental Medicine, vol. 203, no. 8, pp. 2021–2031, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Sadeghi, H. Al-Chaqmaqchi, S. Al-Hashmi et al., “Early-phase GVHD gene expression profile in target versus non-target tissues: kidney, a possible target?” Bone Marrow Transplantation, vol. 48, no. 2, pp. 284–293, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. J.-H. Lee, Y.-D. Joo, H. Kim et al., “Randomized trial of myeloablative conditioning regimens: busulfan plus cyclophosphamide versus busulfan plus fludarabine,” Journal of Clinical Oncology, vol. 31, no. 6, pp. 701–709, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Rambaldi, A. Grassi, A. Masciulli et al., “Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial,” The Lancet Oncology, vol. 16, no. 15, pp. 1525–1536, 2015. View at Publisher · View at Google Scholar
  12. C. Jopling and M. Rosendaal, “A cautionary tale: how to delete mouse haemopoietic stem cells with busulphan,” British Journal of Haematology, vol. 113, no. 4, pp. 970–974, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Kuwatani, Y. Ikarashi, S. Mineishi, M. Asaka, and H. Wakasugi, “An irradiation-free nonmyeloablative bone marrow transplantation model: importance of the balance between donor T-cell number and the intensity of conditioning,” Transplantation, vol. 80, no. 9, pp. 1145–1152, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Sadeghi, N. Aghdami, Z. Hassan et al., “GVHD after chemotherapy conditioning in allogeneic transplanted mice,” Bone Marrow Transplantation, vol. 42, no. 12, pp. 807–818, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. H. A. Bolton, E. Zhu, A. M. Terry et al., “Selective Treg reconstitution during lymphopenia normalizes DC costimulation and prevents graft-versus-host disease,” Journal of Clinical Investigation, vol. 125, no. 9, pp. 3627–3641, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. D. H. Kaplan, B. E. Anderson, J. M. McNiff, D. Jain, M. J. Shlomchik, and W. D. Shlomchik, “Target antigens determine graft-versus-host disease phenotype,” Journal of Immunology, vol. 173, no. 9, pp. 5467–5475, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Mariotti, J. Taylor, P. R. Massey et al., “The Pentostatin plus cyclophosphamide nonmyeloablative regimen induces durable host T cell functional deficits and prevents murine marrow allograft rejection,” Biology of Blood and Marrow Transplantation, vol. 17, no. 5, pp. 620–631, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Dhir, M. Slatter, and R. Skinner, “Recent advances in the management of graft-versus-host disease,” Archives of Disease in Childhood: Education and Practice Edition, vol. 99, no. 12, pp. 1150–1157, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. R. E. Ploemacher, K. W. Johnson, E. J. C. Rombouts et al., “Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model,” Biology of Blood and Marrow Transplantation, vol. 10, no. 4, pp. 236–245, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Bouazzaoui, S. Dickhöfer, M. Kreuz, E. Huber, E. Holler, and D. Wolff, “Cytostatic conditioning in experimental allogeneic bone marrow transplantation: busulfan causes less early gastrointestinal toxicity but Treosulfan results in improved immune reconstitution,” Immunopharmacology and Immunotoxicology, vol. 36, no. 2, pp. 158–164, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Li, H.-L. Chen, N. Bannick et al., “Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice,” Journal of Immunology, vol. 194, no. 3, pp. 1011–1020, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. M. M. Heimesaat, A. Nogai, S. Bereswill et al., “MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease,” Gut, vol. 59, no. 8, pp. 1079–1087, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. A. M. Alousi, J. Bolaños-Meade, and S. J. Lee, “Graft-versus-host disease: state of the science,” Biology of Blood and Marrow Transplantation, vol. 19, no. 1, pp. S102–S108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Riesner, M. Kalupa, Y. Shi, S. Elezkurtaj, and O. Penack, “A preclinical acute GVHD mouse model based on chemotherapy conditioning and MHC-matched transplantation,” Bone Marrow Transplantation, vol. 51, no. 3, pp. 410–417, 2015. View at Publisher · View at Google Scholar
  25. Y. Sun, I. Tawara, T. Toubai, and P. Reddy, “Pathophysiology of acute graft-versus-host disease: recent advances,” Translational Research, vol. 150, no. 4, pp. 197–214, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Leonhardt, S. Grundmann, M. Behe et al., “Inflammatory neovascularization during graft-versus-host disease is regulated by αv integrin and miR-100,” Blood, vol. 121, no. 17, pp. 3307–3318, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Refaeli, L. Van Parijs, S. I. Alexander, and A. K. Abbas, “Interferon γ is required for activation-induced death of T lymphocytes,” Journal of Experimental Medicine, vol. 196, no. 7, pp. 999–1005, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. D. B. Leveson-Gower, J. A. Olson, E. I. Sega et al., “Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism,” Blood, vol. 117, no. 11, pp. 3220–3229, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Nikolic, S. Lee, R. T. Bronson, M. J. Grusby, and M. Sykes, “Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets,” Journal of Clinical Investigation, vol. 105, no. 9, pp. 1289–1298, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Yi, Y. Chen, L. Wang et al., “Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease,” Blood, vol. 114, no. 14, pp. 3101–3112, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. F. J. Hermann, G. M. Rodriguez, K. Doser et al., “Basophils inhibit proliferation of CD4+ T cells in autologous and allogeneic mixed lymphocyte reactions and limit disease activity in a murine model of graft versus host disease,” Immunology, vol. 145, no. 2, pp. 202–212, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. J. A. Olson, D. B. Leveson-Gower, S. Gill, J. Baker, A. Beilhack, and R. S. Negrin, “NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects,” Blood, vol. 115, no. 21, pp. 4293–4301, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. M. A. Ullah, G. R. Hill, and S. Tey, “Functional reconstitution of natural killer cells in allogeneic hematopoietic stem cell transplantation,” Frontiers in Immunology, vol. 7, article 144, 2016. View at Publisher · View at Google Scholar
  34. M. von Bonin and M. Bornhauser, “Concise review: the bone marrow niche as a target of graft versus host disease,” STEM CELLS, vol. 32, no. 6, pp. 1420–1428, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. L. A. Welniak, B. R. Blazar, and W. J. Murphy, “Immunobiology of allogeneic hematopoietic stem cell transplantation,” Annual Review of Immunology, vol. 25, pp. 139–170, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Shono, S. Ueha, Y. Wang et al., “Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation,” Blood, vol. 115, no. 26, pp. 5401–5411, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Haddad, S. Leroy, and R. H. Buckley, “B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment?” Journal of Allergy and Clinical Immunology, vol. 131, no. 4, pp. 994–1000, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. C. C. Dvorak, G.-Y. Hung, B. Horn, E. Dunn, C.-Y. Oon, and M. J. Cowan, “Megadose CD34+ cell grafts improve recovery of T cell engraftment but not B cell immunity in patients with severe combined immunodeficiency disease undergoing haplocompatible nonmyeloablative transplantation,” Biology of Blood and Marrow Transplantation, vol. 14, no. 10, pp. 1125–1133, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Mensen, K. Jöhrens, I. Anagnostopoulos et al., “Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT,” Blood, vol. 124, no. 6, pp. 963–972, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. C. A. Lindemans and A. M. Hanash, “The importance of bone marrow involvement in GVHD,” Blood, vol. 124, no. 6, pp. 837–838, 2014. View at Publisher · View at Google Scholar · View at Scopus